| Names | |
|---|---|
|  Systematic IUPAC name  1-(Benzo[d][1,3]dioxol-5-yl)-2-(dimethylamino)butan-1-one  | |
| Other names  1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one; β-Keto-dimethylbenzodioxolylbutanamine; bk-DMBDB  | |
| Identifiers | |
3D model (JSmol)  | |
| ChemSpider | |
 PubChem CID  | |
| UNII | |
 CompTox Dashboard (EPA)  | |
  | |
  | |
| Properties | |
| C13H17NO3 | |
| Molar mass | 235.283 g·mol−1 | 
| Pharmacology | |
| Legal status | 
  | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).  | |
Dibutylone (bk-DMBDB [2] ) is a stimulant drug of the amphetamine, phenethylamine, cathinone, and phenylisobutylamine families. It is structurally related to butylone, a designer drug that has been detected in products marketed as bath salts or plant food. [3]
In 2018, dibutylone was the third most common drug of the cathinone class to be identified in Drug Enforcement Administration seizures. [4]
In United States, dibutylone is on the list of Schedule I Controlled Substances as a positional isomer of pentylone. [5]